Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Real Estate Credit Investments (RECI)
Manager presentation and Q&A
4th Mar 2026
The Monthly: March 2026
3rd Mar 2026
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
129: Why the bear view of AIM is overdone | Oliver Bedford of Hargreave Hale AIM VCT
Stay up-to-date with the latest research
Sign up to our newsletter
Watch on-demand now -
Event | Tax Advantaged Online Forum: Four distinct approaches to EIS investing
Latest Initiation
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
ICG Enterprise Trust
Financials
Outperformance through every stage of cycle
By
Mark Thomas
06 Jul 2020
Incanthera Ltd
Life Sciences
Preparing Sol for commercialisation
By
Dr Martin Hall
19 Jun 2020
Stay up-to-date with the latest research
Sign up to our newsletter
Arix Bioscience
Life Sciences
With high risk can come high reward
19 Feb 2020
Bank North
Financials
Unquoted SME lender with unique proposition
By
Mark Thomas
16 Dec 2019
Pantheon International Plc
Financials
11.9% average annual NAV growth since 1987
By
Mark Thomas
06 Sep 2019
Real Estate Credit Investments (RECI)
Financials
7%+ yield from well-secured property debt portfolio
By
Mark Thomas
28 Aug 2019
Phoenix Copper Ltd
Mining
First stage in potential world-class copper mine
By
Paul Mylchreest
22 Aug 2019
Anglo Asian Mining
Mining
Prodigious cashflow AND bigger “system” potential
By
Paul Mylchreest
19 Jun 2019
RM Secured Direct Lending
Financials
Predictable revenue streams generating high yield
By
Mark Thomas
05 Jun 2019
Urban Logistics REIT Plc
Property
Plenty of future growth stored up
By
Mike Foster
28 May 2019
Shield Therapeutics Plc
Life Sciences
All in the execution
13 May 2019
Prev
1
2
3
4
5
6
Next
